Nano Dimension Ltd. NNDM

WALTHAM, Mass., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano,” or the “Company”) today announced the appointment of Nadav Kidron to its Board of Directors (the “Board”). As part of the Board’s ongoing strategic review, led by Chairman Phillip Borenstein, the Board intends to establish a Strategy and Capital Allocation Committee to support the Board’s evaluation of capital allocation alternatives, potential returns of excess capital to shareholders

Ongoing Strategic Actions Expected to Reduce Annualized Cash Burn by Approximately $25 Million Announced Agreement to Sell MarkForged, Inc. to Stratasys; Transaction Expected to Close in the Second Half of 2026 Completed Sale of AME and Fabrica Product Lines WALTHAM, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension”, “Nano”, or the “Company”) today reported financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Highlights: Re

Arbe Robotics Ltd. (Nasdaq: ARBE) (TASE: ARBE), a global leader in ultra-high-resolution radar solutions, today announced the appointment of Assaf Pereg, CPA, as the incoming Chief Financial Officer, effective August 30, 2026. Mr. Pereg succeeds Karine Pinto-Flomenboim, who will be departing the Company.

Activists also report to the SEC on Smith & Nephew, Navigator Holdings, Global Net Lease, and Radcom.

Activists also report to the SEC on Metalla Royalty, Xerox Holdings, Angel Oak Mortgage REIT, and Daktronics.

WALTHAM, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano”, or the “Company”) today announced the appointment of Moshe Rozenbaum as Interim Chief Executive Officer (“CEO”), effective immediately. The Company’s Board of Directors (the “Board”) has also appointed Phillip Borenstein as Chairman of the Board. Mr. Rozenbaum will work closely with the Board and the Company’s leadership to support business continuity while the Board evaluates the Comp

WALTHAM, Mass., July 20, 2026 (GLOBE NEWSWIRE) -- In connection with the upcoming July 31, 2026, Extraordinary General Meeting of Shareholders (the “July EGM”), Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano,” or the “Company”) and Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson") today jointly announced a settlement agreement. Under the terms of the agreement executed on July 17, the July EGM will be cancelled. Messrs. Pons, Ro

Ness Ziona, Israel, July 17, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company"), a company focused on advancing Additively Manufactured Electronics (“AME”) for quantum computing infrastructure, today announced that on July 14, 2026, its Board of Directors (the “Board”) appointed Dr. Shlomit Chappel-Ram as an independent director, effective immediately. Dr. Chappel-Ram previously served as Vice President of R&D at Nano Dimension Ltd. (Nasdaq: NNDM), where she le

Enters into Agreement to Terminate Current Corporate Headquarters Lease, Expected to Generate Approximately $25 Million in Cumulative Net Cash SavingsWALTHAM, Mass., July 17, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano,” or the “Company”) today announced that it has entered into an agreement to terminate the lease for its current corporate headquarters, effective December 31, 2026. As part of its ongoing cost savings initiatives, the current management te

Nano Dimension Ltd. (NASDAQ:NNDM) is one of the 10 Fastest Growing Tech Penny Stocks to Buy. On June 16, 2026, Nano Dimension Ltd. (NASDAQ:NNDM) and Infinite Epigenetics issued a shareholder update on the proposed business combination announced on June 15. Nano said it reviewed Murchinson’s recent letter on the proposed transaction and noted that final […]

WALTHAM, Mass.--(BUSINESS WIRE)--Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano,” or the “Company”) today issued the following letter to shareholders regarding its upcoming Extraordinary General Meeting (“EGM”) scheduled for July 31, 2026. Nano's Board of Directors (the “Board”) urges shareholders to carefully evaluate its recommendations and vote accordingly.

Nano Dimension Ltd. (NASDAQ:NNDM) is one of the 8 High Growth Penny Stocks to Buy. On June 15, 2026, Nano Dimension Ltd. (NASDAQ:NNDM) entered into a non-binding term sheet for a proposed business combination with Infinite Epigenetics. The proposed transaction contemplates Nano Dimension, or a successor publicly traded company, acquiring 100% of Infinite Epigenetics through […]

Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano”, or the “Company”) and Infinite Epigenetics™ (“Infinite Epigenetics,” “Infinite”) today issued the following shareholder update to provide additional detail on the proposed business combination announced on June 15, 2026. The Company has carefully reviewed Murchinson’s recent letter regarding the proposed transaction with Infinite.

TORONTO, June 15, 2026--Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson" or "we"), a significant shareholder with approximately 7.4% of the outstanding shares of Nano Dimension Ltd. (NASDAQ: NNDM) ("Nano" or the "Company"), today commented on Nano’s announcement that it has signed a non-binding term sheet with Infinite Epigenetics ("Infinite" or "Infinite Epigenetics") to form a publicly traded, AI-powered health and diagnostics company.1

Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano”) today announced it has entered into a non-binding term sheet for a proposed business combination (“combination”) with Infinite Epigenetics™ (“Infinite Epigenetics,” “Infinite”), an artificial intelligence (“AI”)-powered preventive health and diagnostics company building a proprietary biological AI platform to read, interpret, and apply epigenetic signals at scale. Epigenetics is the science of gene expression, shaped by lifestyle, aging, stress, and environmental factors. While traditional genetics dictates the exact sequence of o